Endophthalmitis most often caused by Staphylococcus

Article

Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it. That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA.

Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it.

That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA. The researchers set out to look for trends related to pathogens and antibiotics over the past 25 years. They reported their results in Ophthalmology.

Other findings:

  • Many antibiotics, among them cephalosporins and methicillin, are associated with a statistically significant trend in increasing microbial resistance.
  • A significant trend toward decreasing microbial resistance against aminoglycosides and imipenem also exists.

The researchers studied 911 eyes with a total of 988 consecutive culture-positive endophthalmitis isolates that had been collected from 1987 to 2011. The pathogens they most frequently found were coagulase-negative Staphylococcus (39.4%), Streptococcus viridans species (12.1%) and Staphylococcus aureus (11.1%). Gram-negative organisms accounted for 10.3% of all isolates and fungi accounted for 4.6% of them.

Two isolates, Enterococcus faecium and Nocardia exalbida, were not susceptible to vancomycin, but the rest of the 725 gram-positive bacteria they tested were susceptible. The researchers tested 94 gram-negative organisms against ceftazidime and found that 2 were of intermediate sensitivity and 6 were resistant.

The researchers found that microbial resistance was associated with 8 antibiotics as time went on. Those 8 were ampicillin, cefazolin, cefotetan, ceftriaxone, cephalothin, clindamycin, erythromycin and methicillin/oxacillin. They saw increasing microbial susceptibility with 3 antibiotics: gentamicin, imipenem and tobramycin.

To read the abstract of the study click here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.